WH-4-023

Catalog No.S7565 Synonyms: KIN001-112, KIN112

WH-4-023 Chemical Structure

Molecular Weight(MW): 568.67

WH-4-023 is a potent and orally active Lck/Src inhibitor with IC50s of 2 nM and 6 nM in cell-free assays, respectively. Exhibits >300-fold selectivity against p38α and KDR. Also potently inhibits SIK (IC50 values are 10, 22 and 60 nM for SIK 1, 2 and 3 respectively) and displays selectivity over a range of closely related kinases.

Size Price Stock Quantity  
USD 147 In stock
USD 477 In stock
USD 997 In stock
Bulk Discount

Free Overnight Delivery on orders over $ 500
Next day delivery by 10:00 a.m. Order now.

Cited by 2 Publications

1 Customer Review

  • (G-I) WB analysis of total LCK, LCK Y505, and Src Y416 expression in ALL-SIL, CCRF-CEM, and TALL-1. Cells were treated with DMSO only (Ctrl), dasatinib, bosutinib, nintedanib, or WH-4-023 overnight at the compound concentrations corresponding to the GI50 at 48 hr. Bos, bosutinib; Das, dasatinib; Nint, nintedanib; WH, WH-4-023.

    Blood, 2017, 130(25):2750-2761. WH-4-023 purchased from Selleck.

Purity & Quality Control

Choose Selective Src Inhibitors

Biological Activity

Description WH-4-023 is a potent and orally active Lck/Src inhibitor with IC50s of 2 nM and 6 nM in cell-free assays, respectively. Exhibits >300-fold selectivity against p38α and KDR. Also potently inhibits SIK (IC50 values are 10, 22 and 60 nM for SIK 1, 2 and 3 respectively) and displays selectivity over a range of closely related kinases.
Targets
Lck [1]
(Cell-free assay)
Src [1]
(Cell-free assay)
2 nM 6 nM
In vitro

WH-4-023 shows little activity on p38 and KDR. [1]

Cell Data
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
human EM-2 cell NYPsTXVwT3Kxd4ToJIlvcGmkaYTpc44h[XO|YYm= NFTPe2lKdmirYnn0bY9vKG:oIHj1cYFvKEWPLUKgZ4VtdCCpcn;3eIghcW5iYTDj[YxtKH[rYXLpcIl1gSCjc4PhfUwhUUN3ME2zMlky\S1yODFOwG0> MULTRW5ITVJ?
human LAMA-84 cell MkfIS5Jwf3SqIHnubIljcXSrb36gZZN{[Xl? MknSTY5pcWKrdHnvckBw\iCqdX3hckBNSU2DLUi0JINmdGxiZ4Lve5RpKGmwIHGgZ4VtdCC4aXHibYxqfHliYYPzZZktKEmFNUC9N{44QGVvME[g{txO NEjlepBUSU6JRWK=
human EoL-1-cell cell MX3Hdo94fGhiaX7obYJqfGmxbjDhd5NigQ>? MXvJcohq[mm2aX;uJI9nKGi3bXHuJGVwVC1zLXPlcIwh[2WubDDndo94fGhiaX6gZUBk\WyuII\pZYJqdGm2eTDhd5NigSxiSVO1NF06NjVzZT2wOkDPxE1? MoG3V2FPT0WU
human MEG-01 cell M37NOWdzd3e2aDDpcohq[mm2aX;uJIF{e2G7 MULJcohq[mm2aX;uJI9nKGi3bXHuJG1GTy1yMTDj[YxtKGe{b4f0bEBqdiCjIHPlcIwhfmmjYnnsbZR6KGG|c3H5MEBKSzVyPUGuOlNmNTB3IN88US=> MlzvV2FPT0WU
human CTV-1 cell MULHdo94fGhiaX7obYJqfGmxbjDhd5NigQ>? MWrJcohq[mm2aX;uJI9nKGi3bXHuJGNVXi1zIHPlcIwh\3Kxd4ToJIlvKGFiY3XscEB3cWGkaXzpeJkh[XO|YYmsJGlEPTB;Mz6xPIUuODVizszN NHzlVGNUSU6JRWK=
human BL-70 cell MlzOS5Jwf3SqIHnubIljcXSrb36gZZN{[Xl? NH6wO5NKdmirYnn0bY9vKG:oIHj1cYFvKEKOLUewJINmdGxiZ4Lve5RpKGmwIHGgZ4VtdCC4aXHibYxqfHliYYPzZZktKEmFNUC9OE44OmVvMEWg{txO NID3[VJUSU6JRWK=
human K-562 cell Moj2S5Jwf3SqIHnubIljcXSrb36gZZN{[Xl? M{jKWGlvcGmkaYTpc44hd2ZiaIXtZY4hUy13NkKgZ4VtdCCpcn;3eIghcW5iYTDj[YxtKH[rYXLpcIl1gSCjc4PhfUwhUUN3ME2wMlAxODF4MjFOwG0> MoTQV2FPT0WU
human BV-173 cell M13EO2dzd3e2aDDpcohq[mm2aX;uJIF{e2G7 MkToTY5pcWKrdHnvckBw\iCqdX3hckBDXi1zN{OgZ4VtdCCpcn;3eIghcW5iYTDj[YxtKH[rYXLpcIl1gSCjc4PhfUwhUUN3ME2wMlAxODVzNDFOwG0> MX7TRW5ITVJ?
human DOHH-2 cell NVvkbHNLT3Kxd4ToJIlvcGmkaYTpc44h[XO|YYm= M2r4VmlvcGmkaYTpc44hd2ZiaIXtZY4hTE:KSD2yJINmdGxiZ4Lve5RpKGmwIHGgZ4VtdCC4aXHibYxqfHliYYPzZZktKEmFNUC9NE4xODB3OUeg{txO MX7TRW5ITVJ?
human A704 cell NWPPfm9oT3Kxd4ToJIlvcGmkaYTpc44h[XO|YYm= MmnrTY5pcWKrdHnvckBw\iCqdX3hckBCPzB2IHPlcIwh\3Kxd4ToJIlvKGFiY3XscEB3cWGkaXzpeJkh[XO|YYmsJGlEPTB;MD6wNFEzPyEQvF2= Mli4V2FPT0WU
human NCI-SNU-16 cell NGDvcG1Iem:5dHigbY5pcWKrdHnvckBie3OjeR?= MmCxTY5pcWKrdHnvckBw\iCqdX3hckBPS0lvU17VMVE3KGOnbHyg[5Jwf3SqIHnuJIEh[2WubDD2bYFjcWyrdImgZZN{[XluIFnDOVA:OC5yMUW3NkDPxE1? NEXRU5pUSU6JRWK=
human LC-2-ad cell NXv2[Jh[T3Kxd4ToJIlvcGmkaYTpc44h[XO|YYm= MXfJcohq[mm2aX;uJI9nKGi3bXHuJGxENTJvYXSgZ4VtdCCpcn;3eIghcW5iYTDj[YxtKH[rYXLpcIl1gSCjc4PhfUwhUUN3ME2wMlAzODN|IN88US=> M4ewPXNCVkeHUh?=
human LB2518-MEL cell M4TCRWdzd3e2aDDpcohq[mm2aX;uJIF{e2G7 M33PfGlvcGmkaYTpc44hd2ZiaIXtZY4hVEJ{NUG4MW1GVCClZXzsJIdzd3e2aDDpckBiKGOnbHygeoli[mmuaYT5JIF{e2G7LDDJR|UxRTBwMES2Olch|ryP M{LHXnNCVkeHUh?=
human D-336MG cell NV3JS4NIT3Kxd4ToJIlvcGmkaYTpc44h[XO|YYm= M3TJRmlvcGmkaYTpc44hd2ZiaIXtZY4hTC1|M{\NS{Bk\WyuIHfyc5d1cCCrbjDhJINmdGxidnnhZoltcXS7IHHzd4F6NCCLQ{WwQVAvODR4OEGg{txO MoXQV2FPT0WU
human LB996-RCC cell Mn\XS5Jwf3SqIHnubIljcXSrb36gZZN{[Xl? NFHIfHBKdmirYnn0bY9vKG:oIHj1cYFvKEyEOUm2MXJESyClZXzsJIdzd3e2aDDpckBiKGOnbHygeoli[mmuaYT5JIF{e2G7LDDJR|UxRTBwMEW2Olgh|ryP MkPBV2FPT0WU
human Becker cell M3jWR2dzd3e2aDDpcohq[mm2aX;uJIF{e2G7 MULJcohq[mm2aX;uJI9nKGi3bXHuJGJm[2uncjDj[YxtKGe{b4f0bEBqdiCjIHPlcIwhfmmjYnnsbZR6KGG|c3H5MEBKSzVyPUCuNFY{QDFizszN M2ewS3NCVkeHUh?=
human LB1047-RCC cell NFGyZ|NIem:5dHigbY5pcWKrdHnvckBie3OjeR?= MXnJcohq[mm2aX;uJI9nKGi3bXHuJGxDOTB2Nz3SR2Mh[2WubDDndo94fGhiaX6gZUBk\WyuII\pZYJqdGm2eTDhd5NigSxiSVO1NF0xNjB5NUmyJO69VQ>? Mn23V2FPT0WU
human KS-1 cell MmXoS5Jwf3SqIHnubIljcXSrb36gZZN{[Xl? M3n4NGlvcGmkaYTpc44hd2ZiaIXtZY4hU1NvMTDj[YxtKGe{b4f0bEBqdiCjIHPlcIwhfmmjYnnsbZR6KGG|c3H5MEBKSzVyPUCuNFc4PThizszN M3LsW3NCVkeHUh?=
human MPP-89 cell MV3Hdo94fGhiaX7obYJqfGmxbjDhd5NigQ>? M4XIUWlvcGmkaYTpc44hd2ZiaIXtZY4hVVCSLUi5JINmdGxiZ4Lve5RpKGmwIHGgZ4VtdCC4aXHibYxqfHliYYPzZZktKEmFNUC9NE4xQDJ{OTFOwG0> M2fIdXNCVkeHUh?=
human RXF393 cell NInFSIVIem:5dHigbY5pcWKrdHnvckBie3OjeR?= NUPN[WliUW6qaXLpeIlwdiCxZjDoeY1idiCUWF[zPVMh[2WubDDndo94fGhiaX6gZUBk\WyuII\pZYJqdGm2eTDhd5NigSxiSVO1NF0xNjFyNkOzJO69VQ>? NHPlfmpUSU6JRWK=
LB831-BLC cell MXvHdo94fGhiaX7obYJqfGmxbjDhd5NigQ>? MXrJcohq[mm2aX;uJI9nKGi3bXHuJGxDQDNzLVLMR{Bk\WyuIHfyc5d1cCCrbjDhJINmdGxidnnhZoltcXS7IHHzd4F6NCCLQ{WwQVAvOTJ5MUWg{txO NEW2dmpUSU6JRWK=
HUTU-80 cell NVL6WIdoT3Kxd4ToJIlvcGmkaYTpc44h[XO|YYm= M4fQPWlvcGmkaYTpc44hd2ZiaIXtZY4hUFWWVT24NEBk\WyuIHfyc5d1cCCrbjDhJINmdGxidnnhZoltcXS7IHHzd4F6NCCLQ{WwQVAvOTd3Mkmg{txO MkDaV2FPT0WU
A498 cell M3nIOGdzd3e2aDDpcohq[mm2aX;uJIF{e2G7 NVLWV|NmUW6qaXLpeIlwdiCxZjDoeY1idiCDNEm4JINmdGxiZ4Lve5RpKGmwIHGgZ4VtdCC4aXHibYxqfHliYYPzZZktKEmFNUC9NE4yQDl2NTFOwG0> NWfQNFFEW0GQR1XS
MZ1-PC cell MVPHdo94fGhiaX7obYJqfGmxbjDhd5NigQ>? MVvJcohq[mm2aX;uJI9nKGi3bXHuJG1bOS2SQzDj[YxtKGe{b4f0bEBqdiCjIHPlcIwhfmmjYnnsbZR6KGG|c3H5MEBKSzVyPUCuNlI4OTZizszN MnOxV2FPT0WU
TE-8 cell NVfCfJlZT3Kxd4ToJIlvcGmkaYTpc44h[XO|YYm= NHrseHZKdmirYnn0bY9vKG:oIHj1cYFvKFSHLUigZ4VtdCCpcn;3eIghcW5iYTDj[YxtKH[rYXLpcIl1gSCjc4PhfUwhUUN3ME2wMlI{QTJ2IN88US=> MXHTRW5ITVJ?
MFH-ino cell  MUXHdo94fGhiaX7obYJqfGmxbjDhd5NigQ>? MUXJcohq[mm2aX;uJI9nKGi3bXHuJG1HUC2rbn:gZ4VtdCCpcn;3eIghcW5iYTDj[YxtKH[rYXLpcIl1gSCjc4PhfUwhUUN3ME2wMlI{QTJ3IN88US=> Mk\pV2FPT0WU
TE-15 cell NFrnd4JIem:5dHigbY5pcWKrdHnvckBie3OjeR?= NIDSZW1KdmirYnn0bY9vKG:oIHj1cYFvKFSHLUG1JINmdGxiZ4Lve5RpKGmwIHGgZ4VtdCC4aXHibYxqfHliYYPzZZktKEmFNUC9NE4zPDJ5NjFOwG0> Mn\2V2FPT0WU
NTERA-S-cl-D1 cell MWrHdo94fGhiaX7obYJqfGmxbjDhd5NigQ>? NVXSbmU3UW6qaXLpeIlwdiCxZjDoeY1idiCQVFXSRU1UNWOuLVSxJINmdGxiZ4Lve5RpKGmwIHGgZ4VtdCC4aXHibYxqfHliYYPzZZktKEmFNUC9NE4zQDh3NTFOwG0> MlH6V2FPT0WU
COLO-829 cell M3XCcmdzd3e2aDDpcohq[mm2aX;uJIF{e2G7 MYLJcohq[mm2aX;uJI9nKGi3bXHuJGNQVE9vOEK5JINmdGxiZ4Lve5RpKGmwIHGgZ4VtdCC4aXHibYxqfHliYYPzZZktKEmFNUC9NE4{OTJzMjFOwG0> NETJNHVUSU6JRWK=
SW684 cell NEDxPVBIem:5dHigbY5pcWKrdHnvckBie3OjeR?= MYPJcohq[mm2aX;uJI9nKGi3bXHuJHNYPjh2IHPlcIwh\3Kxd4ToJIlvKGFiY3XscEB3cWGkaXzpeJkh[XO|YYmsJGlEPTB;MD6zNlU5QCEQvF2= Mkm0V2FPT0WU
OS-RC-2 cell NGG1UFJIem:5dHigbY5pcWKrdHnvckBie3OjeR?= NUjUTVI5UW6qaXLpeIlwdiCxZjDoeY1idiCRUz3SR{0zKGOnbHyg[5Jwf3SqIHnuJIEh[2WubDD2bYFjcWyrdImgZZN{[XluIFnDOVA:OC5|NUCxNUDPxE1? MkfMV2FPT0WU
IST-MES1 cell MkfJS5Jwf3SqIHnubIljcXSrb36gZZN{[Xl? MXrJcohq[mm2aX;uJI9nKGi3bXHuJGlUXC2PRWOxJINmdGxiZ4Lve5RpKGmwIHGgZ4VtdCC4aXHibYxqfHliYYPzZZktKEmFNUC9NE4{PTd{MzFOwG0> NELD[JhUSU6JRWK=
SNB75 cell MlO5S5Jwf3SqIHnubIljcXSrb36gZZN{[Xl? NHLHc49KdmirYnn0bY9vKG:oIHj1cYFvKFOQQke1JINmdGxiZ4Lve5RpKGmwIHGgZ4VtdCC4aXHibYxqfHliYYPzZZktKEmFNUC9NE4{PTd5NDFOwG0> MYPTRW5ITVJ?
SW954 cell M3LLeGdzd3e2aDDpcohq[mm2aX;uJIF{e2G7 NU\FfXl3UW6qaXLpeIlwdiCxZjDoeY1idiCVV{m1OEBk\WyuIHfyc5d1cCCrbjDhJINmdGxidnnhZoltcXS7IHHzd4F6NCCLQ{WwQVAvOzdzNkOg{txO Mn3nV2FPT0WU
RCC10RGB cell MoXMS5Jwf3SqIHnubIljcXSrb36gZZN{[Xl? NWP3NWJTUW6qaXLpeIlwdiCxZjDoeY1idiCUQ1OxNHJISiClZXzsJIdzd3e2aDDpckBiKGOnbHygeoli[mmuaYT5JIF{e2G7LDDJR|UxRTBwNEK2N|Eh|ryP MVHTRW5ITVJ?
VA-ES-BJ cell MVzHdo94fGhiaX7obYJqfGmxbjDhd5NigQ>? MnHOTY5pcWKrdHnvckBw\iCqdX3hckBXSS2HUz3CTkBk\WyuIHfyc5d1cCCrbjDhJINmdGxidnnhZoltcXS7IHHzd4F6NCCLQ{WwQVAvPDZ{NjFOwG0> NEX3b5RUSU6JRWK=
NCI-H1648 cell NITRcHdIem:5dHigbY5pcWKrdHnvckBie3OjeR?= NEDvfnpKdmirYnn0bY9vKG:oIHj1cYFvKE6FST3INVY1QCClZXzsJIdzd3e2aDDpckBiKGOnbHygeoli[mmuaYT5JIF{e2G7LDDJR|UxRTBwNUG1PFIh|ryP MVnTRW5ITVJ?
PF-382 cell MmPaS5Jwf3SqIHnubIljcXSrb36gZZN{[Xl? MonDTY5pcWKrdHnvckBw\iCqdX3hckBRTi1|OEKgZ4VtdCCpcn;3eIghcW5iYTDj[YxtKH[rYXLpcIl1gSCjc4PhfUwhUUN3ME2wMlcxPzZ|IN88US=> M{PxXHNCVkeHUh?=
human Daudi cell MofwS5Jwf3SqIHnubIljcXSrb36gZZN{[Xl? MUHJcohq[mm2aX;uJI9nKGi3bXHuJGRifWSrIHPlcIwh\3Kxd4ToJIlvKGFiY3XscEB3cWGkaXzpeJkh[XO|YYmsJGlEPTB;MD63NVQyOSEQvF2= M4DzUnNCVkeHUh?=
SW982 cell NFHqdGtIem:5dHigbY5pcWKrdHnvckBie3OjeR?= MXXJcohq[mm2aX;uJI9nKGi3bXHuJHNYQTh{IHPlcIwh\3Kxd4ToJIlvKGFiY3XscEB3cWGkaXzpeJkh[XO|YYmsJGlEPTB;MD64OVgyQSEQvF2= NV7KOnVyW0GQR1XS
SW872 cell NVPOT|Q2T3Kxd4ToJIlvcGmkaYTpc44h[XO|YYm= NV:1Z3JQUW6qaXLpeIlwdiCxZjDoeY1idiCVV{i3NkBk\WyuIHfyc5d1cCCrbjDhJINmdGxidnnhZoltcXS7IHHzd4F6NCCLQ{WwQVAvQDZ2NUig{txO NIju[W1USU6JRWK=
TE-12 cell M{nS[Gdzd3e2aDDpcohq[mm2aX;uJIF{e2G7 MmfMTY5pcWKrdHnvckBw\iCqdX3hckBVTS1zMjDj[YxtKGe{b4f0bEBqdiCjIHPlcIwhfmmjYnnsbZR6KGG|c3H5MEBKSzVyPUCuPFg5OzFizszN M1[xfXNCVkeHUh?=
human HOP-62 cell MlHZS5Jwf3SqIHnubIljcXSrb36gZZN{[Xl? NWj2SJYxUW6qaXLpeIlwdiCxZjDoeY1idiCKT2CtOlIh[2WubDDndo94fGhiaX6gZUBk\WyuII\pZYJqdGm2eTDhd5NigSxiSVO1NF0xNjlzNUm5JO69VQ>? NUTHNGlwW0GQR1XS
human NOS-1 cell MUHHdo94fGhiaX7obYJqfGmxbjDhd5NigQ>? MWXJcohq[mm2aX;uJI9nKGi3bXHuJG5QWy1zIHPlcIwh\3Kxd4ToJIlvKGFiY3XscEB3cWGkaXzpeJkh[XO|YYmsJGlEPTB;MD65OVA1PSEQvF2= M2nWe3NCVkeHUh?=
human BL-41 cell NGm5WVVIem:5dHigbY5pcWKrdHnvckBie3OjeR?= MmH0TY5pcWKrdHnvckBw\iCqdX3hckBDVC12MTDj[YxtKGe{b4f0bEBqdiCjIHPlcIwhfmmjYnnsbZR6KGG|c3H5MEBKSzVyPUGuNFAxOTNizszN M4fXS3NCVkeHUh?=
human TGBC24TKB cell MlvFS5Jwf3SqIHnubIljcXSrb36gZZN{[Xl? NGDIbXJKdmirYnn0bY9vKG:oIHj1cYFvKFSJQlOyOHRMSiClZXzsJIdzd3e2aDDpckBiKGOnbHygeoli[mmuaYT5JIF{e2G7LDDJR|UxRTFwMEO4N|Eh|ryP NF3McmhUSU6JRWK=
human KGN cell MmjjS5Jwf3SqIHnubIljcXSrb36gZZN{[Xl? NX[2cFNuUW6qaXLpeIlwdiCxZjDoeY1idiCNR16gZ4VtdCCpcn;3eIghcW5iYTDj[YxtKH[rYXLpcIl1gSCjc4PhfUwhUUN3ME2xMlA2OjFizszN M3nQ[HNCVkeHUh?=
human TK10 cell M1GxVGdzd3e2aDDpcohq[mm2aX;uJIF{e2G7 NIfUPIxKdmirYnn0bY9vKG:oIHj1cYFvKFSNMUCgZ4VtdCCpcn;3eIghcW5iYTDj[YxtKH[rYXLpcIl1gSCjc4PhfUwhUUN3ME2xMlA5PDF6IN88US=> M33rWHNCVkeHUh?=
human GB-1 cell NFuwZnlIem:5dHigbY5pcWKrdHnvckBie3OjeR?= NHf6bFBKdmirYnn0bY9vKG:oIHj1cYFvKEeELUGgZ4VtdCCpcn;3eIghcW5iYTDj[YxtKH[rYXLpcIl1gSCjc4PhfUwhUUN3ME2xMlE3ODZ2IN88US=> M2DZVHNCVkeHUh?=
human GCIY cell MXXHdo94fGhiaX7obYJqfGmxbjDhd5NigQ>? NHv5eHlKdmirYnn0bY9vKG:oIHj1cYFvKEeFSWmgZ4VtdCCpcn;3eIghcW5iYTDj[YxtKH[rYXLpcIl1gSCjc4PhfUwhUUN3ME2xMlI{ODFizszN MkDwV2FPT0WU
human LXF-289 cell MmnwS5Jwf3SqIHnubIljcXSrb36gZZN{[Xl? MnjqTY5pcWKrdHnvckBw\iCqdX3hckBNYEZvMki5JINmdGxiZ4Lve5RpKGmwIHGgZ4VtdCC4aXHibYxqfHliYYPzZZktKEmFNUC9NU4zPzJ3NjFOwG0> NXLrUmxqW0GQR1XS
RL95-2 cell M4H2T2dzd3e2aDDpcohq[mm2aX;uJIF{e2G7 MX7Jcohq[mm2aX;uJI9nKGi3bXHuJHJNQTVvMjDj[YxtKGe{b4f0bEBqdiCjIHPlcIwhfmmjYnnsbZR6KGG|c3H5MEBKSzVyPUGuN|I1OzZizszN M{DwPHNCVkeHUh?=
human SW962 cell Mnz4S5Jwf3SqIHnubIljcXSrb36gZZN{[Xl? M1;QUWlvcGmkaYTpc44hd2ZiaIXtZY4hW1d7NkKgZ4VtdCCpcn;3eIghcW5iYTDj[YxtKH[rYXLpcIl1gSCjc4PhfUwhUUN3ME2xMlM{PzR{IN88US=> MVjTRW5ITVJ?
human HT-144 cell NF;3OGhIem:5dHigbY5pcWKrdHnvckBie3OjeR?= M3r4bWlvcGmkaYTpc44hd2ZiaIXtZY4hUFRvMUS0JINmdGxiZ4Lve5RpKGmwIHGgZ4VtdCC4aXHibYxqfHliYYPzZZktKEmFNUC9NU41PDVzNzFOoI0> NXnIXo1kW0GQR1XS
human IST-SL2 cell MWfHdo94fGhiaX7obYJqfGmxbjDhd5NigQ>? MW\Jcohq[mm2aX;uJI9nKGi3bXHuJGlUXC2VTEKgZ4VtdCCpcn;3eIghcW5iYTDj[YxtKH[rYXLpcIl1gSCjc4PhfUwhUUN3ME2xMlQ4PDJzIN88US=> MmjkV2FPT0WU
human NB6 cell MkHGS5Jwf3SqIHnubIljcXSrb36gZZN{[Xl? MkHuTY5pcWKrdHnvckBw\iCqdX3hckBPSjZiY3XscEBoem:5dHigbY4h[SClZXzsJJZq[WKrbHn0fUBie3OjeTygTWM2OD1zLk[5Olk5KM7:TR?= M4nDcXNCVkeHUh?=
human SF126 cell NWT6SGNKT3Kxd4ToJIlvcGmkaYTpc44h[XO|YYm= MXvJcohq[mm2aX;uJI9nKGi3bXHuJHNHOTJ4IHPlcIwh\3Kxd4ToJIlvKGFiY3XscEB3cWGkaXzpeJkh[XO|YYmsJGlEPTB;MT63N|E4QCEQvF2= MVjTRW5ITVJ?
human BOKU cell NUP5b4dQT3Kxd4ToJIlvcGmkaYTpc44h[XO|YYm= NGLWUZFKdmirYnn0bY9vKG:oIHj1cYFvKEKRS2WgZ4VtdCCpcn;3eIghcW5iYTDj[YxtKH[rYXLpcIl1gSCjc4PhfUwhUUN3ME2xMlgxPTJ5IN88US=> MVPTRW5ITVJ?
human BB30-HNC cell MmjYS5Jwf3SqIHnubIljcXSrb36gZZN{[Xl? Mkn2TY5pcWKrdHnvckBw\iCqdX3hckBDSjNyLVjOR{Bk\WyuIHfyc5d1cCCrbjDhJINmdGxidnnhZoltcXS7IHHzd4F6NCCLQ{WwQVEvQDV2N{Kg{txO NVvI[YVtW0GQR1XS
human KLE cell MnPlS5Jwf3SqIHnubIljcXSrb36gZZN{[Xl? MVvJcohq[mm2aX;uJI9nKGi3bXHuJGtNTSClZXzsJIdzd3e2aDDpckBiKGOnbHygeoli[mmuaYT5JIF{e2G7LDDJR|UxRTFwOE[yN|Ih|ryP M2DpZXNCVkeHUh?=
human MLMA cell MmDwS5Jwf3SqIHnubIljcXSrb36gZZN{[Xl? M{PZXWlvcGmkaYTpc44hd2ZiaIXtZY4hVUyPQTDj[YxtKGe{b4f0bEBqdiCjIHPlcIwhfmmjYnnsbZR6KGG|c3H5MEBKSzVyPUGuPVI{OSEQvF2= MmHlV2FPT0WU
human KINGS-1 cell NWrqN4plT3Kxd4ToJIlvcGmkaYTpc44h[XO|YYm= MmjhTY5pcWKrdHnvckBw\iCqdX3hckBMUU6JUz2xJINmdGxiZ4Lve5RpKGmwIHGgZ4VtdCC4aXHibYxqfHliYYPzZZktKEmFNUC9NU46Pjh7NzFOwG0> MluzV2FPT0WU
human ES6 cell MYXHdo94fGhiaX7obYJqfGmxbjDhd5NigQ>? NFXmRWtKdmirYnn0bY9vKG:oIHj1cYFvKEWVNjDj[YxtKGe{b4f0bEBqdiCjIHPlcIwhfmmjYnnsbZR6KGG|c3H5MEBKSzVyPUKuNFU1ODFizszN NF7OVIZUSU6JRWK=
human SH-4 cell NHzJdFZIem:5dHigbY5pcWKrdHnvckBie3OjeR?= M1m5e2lvcGmkaYTpc44hd2ZiaIXtZY4hW0hvNDDj[YxtKGe{b4f0bEBqdiCjIHPlcIwhfmmjYnnsbZR6KGG|c3H5MEBKSzVyPUKuNVIxPTVizszN MWTTRW5ITVJ?
human D-263MG cell NX\LendDT3Kxd4ToJIlvcGmkaYTpc44h[XO|YYm= M4XXW2lvcGmkaYTpc44hd2ZiaIXtZY4hTC1{NkPNS{Bk\WyuIHfyc5d1cCCrbjDhJINmdGxidnnhZoltcXS7IHHzd4F6NCCLQ{WwQVIvOjh6NUOg{txO M3XoT3NCVkeHUh?=
human SF268 cell NEXXZnRIem:5dHigbY5pcWKrdHnvckBie3OjeR?= MWPJcohq[mm2aX;uJI9nKGi3bXHuJHNHOjZ6IHPlcIwh\3Kxd4ToJIlvKGFiY3XscEB3cWGkaXzpeJkh[XO|YYmsJGlEPTB;Mj60PFY5OiEQvF2= NFPkO|ZUSU6JRWK=
human NB17 cell NHnoNZRIem:5dHigbY5pcWKrdHnvckBie3OjeR?= MWDJcohq[mm2aX;uJI9nKGi3bXHuJG5DOTdiY3XscEBoem:5dHigbY4h[SClZXzsJJZq[WKrbHn0fUBie3OjeTygTWM2OD1{Lk[yPFc2KM7:TR?= NEPxOYJUSU6JRWK=
human DMS-114 cell NWnOXGV6T3Kxd4ToJIlvcGmkaYTpc44h[XO|YYm= MmfzTY5pcWKrdHnvckBw\iCqdX3hckBFVVNvMUG0JINmdGxiZ4Lve5RpKGmwIHGgZ4VtdCC4aXHibYxqfHliYYPzZZktKEmFNUC9Nk44QTB{MjFOwG0> Ml7aV2FPT0WU
MC116 cell MYLHdo94fGhiaX7obYJqfGmxbjDhd5NigQ>? NYGwcZF2UW6qaXLpeIlwdiCxZjDoeY1idiCPQ{GxOkBk\WyuIHfyc5d1cCCrbjDhJINmdGxidnnhZoltcXS7IHHzd4F6NCCLQ{WwQVIvQDV5MESg{txO NUC0c3J6W0GQR1XS
human NCI-H747 cell MmPLS5Jwf3SqIHnubIljcXSrb36gZZN{[Xl? NFLRd3ZKdmirYnn0bY9vKG:oIHj1cYFvKE6FST3IO|Q4KGOnbHyg[5Jwf3SqIHnuJIEh[2WubDD2bYFjcWyrdImgZZN{[XluIFnDOVA:PS55NEG1PUDPxE1? M2rwNnNCVkeHUh?=
human A388 cell NXPmUY9yT3Kxd4ToJIlvcGmkaYTpc44h[XO|YYm= M3TtZWlvcGmkaYTpc44hd2ZiaIXtZY4hSTN6ODDj[YxtKGe{b4f0bEBqdiCjIHPlcIwhfmmjYnnsbZR6KGG|c3H5MEBKSzVyPUG0MlY4PThizszN NF;oeVNUSU6JRWK=

... Click to View More Cell Line Experimental Data

Protocol

Solubility (25°C)

In vitro DMSO 12 mg/mL warmed (21.1 mM)
Ethanol 6 mg/mL warmed (10.55 mM)
Water Insoluble
In vivo Add solvents to the product individually and in order(Data is from Selleck tests instead of citations):
5% DMSO+30% PEG 300+5% Tween 80+ddH2O
For best results, use promptly after mixing.
1mg/mL

* Please note that Selleck tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations.

Chemical Information

Molecular Weight 568.67
Formula

C32H36N6O4

CAS No. 837422-57-8
Storage powder
in solvent
Synonyms KIN001-112, KIN112

Bio Calculators

Molarity Calculator

Molarity Calculator

Calculate the mass, volume or concentration required for a solution. The Selleck molarity calculator is based on the following equation:

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

  • Mass
    Concentration
    Volume
    Molecular Weight

*When preparing stock solutions, please always use the batch-specific molecular weight of the product found on the via label and MSDS / COA (available on product pages).

Dilution Calculator

Dilution Calculator

Calculate the dilution required to prepare a stock solution. The Selleck dilution calculator is based on the following equation:

Concentration (start) x Volume (start) = Concentration (final) x Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2 ( Input Output )

  • C1
    V1
    C2
    V2

* When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / COA (available online).

The Serial Dilution Calculator Equation

  • Serial Dilutions

  • Computed Result

  • C1=C0/X C1: LOG(C1):
    C2=C1/X C2: LOG(C2):
    C3=C2/X C3: LOG(C3):
    C4=C3/X C4: LOG(C4):
    C5=C4/X C5: LOG(C5):
    C6=C5/X C6: LOG(C6):
    C7=C6/X C7: LOG(C7):
    C8=C7/X C8: LOG(C8):
Molecular Weight Calculator

Molecular Weight Calculator

Enter the chemical formula of a compound to calculate its molar mass and elemental composition:

Total Molecular Weight: g/mol

Tip: Chemical formula is case sensitive. C10H16N2O2 c10h16n2o2

Instructions to calculate molar mass (molecular weight) of a chemical compound:

To calculate molar mass of a chemical compound, please enter its chemical formula and click 'Calculate'.

Definitions of molecular mass, molecular weight, molar mass and molar weight:

Molecular mass (molecular weight) is the mass of one molecule of a substance and is expressed in the unified atomic mass units (u). (1 u is equal to 1/12 the mass of one atom of carbon-12)
Molar mass (molar weight) is the mass of one mole of a substance and is expressed in g/mol.

Molarity Calculator

Mass Concentration Volume Molecular Weight

Tech Support

Answers to questions you may have can be found in the inhibitor handling instructions. Topics include how to prepare stock solutions, how to store inhibitors, and issues that need special attention for cell-based assays and animal experiments.

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

  • * Indicates a Required Field

Src Signaling Pathway Map

Related Src Products0

Tags: buy WH-4-023 | WH-4-023 supplier | purchase WH-4-023 | WH-4-023 cost | WH-4-023 manufacturer | order WH-4-023 | WH-4-023 distributor
×
Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID